HUDDINGE, Sweden, Jan. 15, 2024 /PRNewswire/ — XNK Therapeutics AB (‘XNK’) today announced that evencaleucel has received a scientific recommendation from the Committee for Advanced Therapies (CAT) of the European Medicines Agency (EMA). This recommendation classifies evencaleucel as a…